
EAA (essential amino acids)
EAAs (Essential Amino Acids) are the 9 amino acids that the human body cannot synthesize in sufficient quantities and must obtain through the diet. In the “recovery” context, the main interest concerns their ability to stimulate muscle protein synthesis (MPS) and contribute to the maintenance of lean mass, especially when total protein intake is suboptimal or in catabolic conditions.
Nutritional support for recovery: muscle protein synthesis and nitrogen balance
EAAs (Essential Amino Acids) are the 9 amino acids that the human body cannot synthesize in sufficient quantities and must obtain through the diet. In the “recovery” context, the main interest concerns their ability to stimulate muscle protein synthesis (MPS) and contribute to the maintenance of lean mass, especially when total protein intake is suboptimal or in catabolic conditions.
Mechanism of action
1) Stimulation of muscle protein synthesis (MPS): leucine acts as a nutritional signal that activates anabolic pathways (e.g. mTORC1) and increases the initiation of protein translation; the other EAAs provide the building blocks needed for synthesis. 2) Net protein balance: EAA intake increases the plasma availability of essential amino acids, promoting a positive protein balance (MPS > MPB), especially in the postprandial/post-exercise period. 3) Reduction of the “limiting amino acid” constraint: a complete mixture reduces the likelihood that protein synthesis will be constrained by the deficiency of a specific EAA (more relevant with low-protein diets or incomplete plant proteins). 4) Recovery support: indirectly, by improving the availability of substrates for tissue repair and remodeling after mechanical/metabolic stress.
Supported benefits
- Acute increase in muscle protein synthesis (MPS) compared with fasting, especially if the mixture contains an adequate amount of leucine (strong)
- Improved net protein balance in conditions of insufficient protein intake or in populations at risk of losing lean mass (moderate)
- Support for maintaining lean mass during energy restriction, if included within an appropriate dietary context (moderate)
- Reduction in some subjective markers of soreness/fatigue in some studies, with variable results (limited)
- Possible usefulness in older adults with “anabolic resistance” (the need for higher protein/leucine stimuli to activate MPS) (emerging)
Safety & side effects
- Gastrointestinal disturbances (nausea, bloating, diarrhea), especially with high doses or rapid intake
- Headache or a feeling of “queasiness” in sensitive individuals (non-specific, reported anecdotally and in some studies)
- Possible worsening of control of certain metabolic conditions if used improperly (e.g. excessive overall protein intake), depending on the dietary context
FAQ
Are EAAs and BCAAs the same thing?
No. BCAAs (leucine, isoleucine, valine) are a subset of EAAs. A mixture containing only BCAAs does not provide all the precursors needed to maximize the synthesis of new proteins if other EAAs become limiting.
Are EAAs useful if I already get enough protein from my diet?
If total protein intake and its distribution across meals are already adequate, adding EAAs may offer marginal or redundant benefits. Their usefulness tends to increase when protein intake is low, appetite is reduced, or the protein quality of the diet is limited.
What is the role of leucine in EAAs?
Leucine is a powerful nutritional signal for the activation of anabolic pathways (e.g. mTORC1) and helps “trigger” MPS. However, without the other EAAs, protein synthesis may be limited by the lack of substrates.
Do EAAs improve DOMS (muscle soreness)?
The evidence is heterogeneous: some studies report modest reductions in soreness or markers of muscle damage, while others show no significant differences. When present, the effect appears to depend on the training protocol, dose, nutritional status, and the measures used.
Are there risks for the kidneys?
In people with normal kidney function, intake within studied ranges is generally considered safe. In the presence of kidney disease or risk factors, the increased nitrogen load may be problematic and requires clinical evaluation.
The information provided is for informational and educational purposes only. It does not constitute medical advice. Use must be assessed and authorized by a qualified healthcare professional.
Mechanism of action
1) Stimulation of muscle protein synthesis (MPS): leucine acts as a nutritional signal that activates anabolic pathways (e.g. mTORC1) and increases the initiation of protein translation; the other EAAs provide the building blocks needed for synthesis. 2) Net protein balance: EAA intake increases the plasma availability of essential amino acids, promoting a positive protein balance (MPS > MPB), especially in the post-meal/post-exercise period. 3) Reduction of the “limiting amino acid” constraint: a complete mixture reduces the likelihood that protein synthesis is constrained by the lack of a specific EAA (more relevant with low-protein diets or incomplete plant proteins). 4) Recovery support: indirectly, by improving the availability of substrates for tissue repair and remodeling after mechanical/metabolic stress.
Scientific benefits
Contraindications
- Chronic kidney disease or reduced kidney function: the increased nitrogen/protein load may require clinical supervision
- Advanced liver disease: nitrogen and amino acid management should be clinically evaluated
- Disorders of amino acid metabolism (e.g. MSUD and other aminoacidopathies): contraindicated unless specifically indicated by a specialist
- Pregnancy/breastfeeding: use of supplements that is not essential should be evaluated with a healthcare professional for safety and necessity
- Pediatric age: avoid unsupervised use
Side effects
- Gastrointestinal disturbances (nausea, bloating, diarrhea), especially with high doses or rapid intake
- Headache or a feeling of “nausea” in sensitive individuals (non-specific, reported anecdotally and in some studies)
- Possible worsening of control of some metabolic conditions if used improperly (e.g. overall excess protein intake), depending on the dietary context
Interactions
- Levodopa: amino acids may compete for intestinal transporters and across the blood-brain barrier; protein timing management is clinically relevant in some patients
- Drugs that affect kidney function (e.g. some diuretics/nephrotoxic agents): caution in the general clinical context
- Diabetes therapies: EAAs may influence satiety and insulin response variably; clinical monitoring if necessary
- Other protein/amino acid supplements: risk of excessive total intake and greater likelihood of GI disturbances
Regulatory status
EAAs are commonly marketed as dietary supplements. They are not drugs; health and performance claims are regulated and vary by country/jurisdiction. In sports, EAAs are not typically prohibited substances, but contamination with banned substances is a supply-chain risk for some uncertified products.
Supplements and peptides
RecoveryBcaa
BCAAs (branched-chain amino acids) are three essential amino acids—leucine, isoleucine, and valine—particularly…
RecoveryComplete electrolytes
“Complete electrolytes” refers to formulations that mainly combine sodium (Na+), potassium (K+), chloride (Cl−),…
RecoveryGlycine
Glycine is the simplest amino acid and participates in numerous biological processes: collagen synthesis, glutathione…